- Home
- CVAC vs VSAT Comparison
CVAC vs VSAT Comparison
Compare CVAC & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- VSAT
- Stock Information
- Founded
- CVAC 2000
- VSAT 1986
- Country
- CVAC Germany
- VSAT United States
- Employees
- CVAC N/A
- VSAT N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- VSAT Radio And Television Broadcasting And Communications Equipment
- Sector
- CVAC Health Care
- VSAT Technology
- Exchange
- CVAC Nasdaq
- VSAT Nasdaq
- Market Cap
- CVAC 764.4M
- VSAT 1.2B
- IPO Year
- CVAC 2020
- VSAT 1996
- Fundamental
- Price
- CVAC $5.39
- VSAT $16.28
- Analyst Decision
- CVAC Hold
- VSAT Buy
- Analyst Count
- CVAC 3
- VSAT 7
- Target Price
- CVAC $6.83
- VSAT $20.00
- AVG Volume (30 Days)
- CVAC 2.2M
- VSAT 5.0M
- Earning Date
- CVAC 08-14-2025
- VSAT 08-06-2025
- Dividend Yield
- CVAC N/A
- VSAT N/A
- EPS Growth
- CVAC N/A
- VSAT N/A
- EPS
- CVAC 0.87
- VSAT N/A
- Revenue
- CVAC $566,039,775.00
- VSAT $4,519,571,000.00
- Revenue This Year
- CVAC N/A
- VSAT $4.46
- Revenue Next Year
- CVAC $24.04
- VSAT $3.58
- P/E Ratio
- CVAC $6.29
- VSAT N/A
- Revenue Growth
- CVAC 787.60
- VSAT 5.50
- 52 Week Low
- CVAC $2.37
- VSAT $6.69
- 52 Week High
- CVAC $5.72
- VSAT $26.70
- Technical
- Relative Strength Index (RSI)
- CVAC 65.91
- VSAT 85.45
- Support Level
- CVAC $5.33
- VSAT $14.31
- Resistance Level
- CVAC $5.58
- VSAT $14.76
- Average True Range (ATR)
- CVAC 0.10
- VSAT 0.90
- MACD
- CVAC -0.04
- VSAT 0.26
- Stochastic Oscillator
- CVAC 41.67
- VSAT 95.09
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About VSAT ViaSat Inc.
Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.